LILRB2 (leukocyte immunoglobulin like receptor B2)

symbol:
LILRB2
locus group:
protein-coding gene
location:
19q13.4
gene_family:
CD molecules|Immunoglobulin-like domain containing|Leukocyte immunoglobulin-like receptors
alias symbol:
LIR-2|ILT4|MIR-10|LIR2|CD85d|MIR10
alias name:
myeloid inhibitory receptor 10|leu…
entrez id:
10288
ensembl gene id:
ENSG00000131042
ucsc gene id:
uc032idl.2
refseq accession:
NM_001080978
hgnc_id:
HGNC:6606
approved reserved:
2000-01-11
19q13.4
基因染色体位置图

This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

此基因是白细胞免疫球蛋白样受体(LIR)家族,其在染色体区域19q13.4基因簇中发现的成员。所编码的蛋白质属于亚家族B级包含两个或四个细胞外免疫球蛋白结构域,跨膜结构域,并且两个到四个细胞质免疫受体基于酪氨酸的抑制基序(ITIMs)LIR受体。它结合于MHC I类分子上的抗原呈递细胞和转导,抑制一种免疫应答的刺激作用的负信号的受体在免疫细胞中表达。它被认为是控制炎症反应和细胞毒性,以帮助集中的免疫反应并限制自身反应性。已发现该基因编码不同亚型的多个抄本变形。 [由RefSeq的,2008年7月提供]

CCND1基因的碱基序列:[NCBI]
Loading Gene Browser...
LILRB2基因的碱基突变:           仅显示部分snp
rs369987       rs369987       rs370269       rs370269       rs391371       rs391371       rs394983       rs394983       rs417603       rs417603       rs422948       rs422948       rs430079       rs430079       rs434127       rs434127       rs441822      

LILRB2基因在不同组织中的表达:    [UniProt]

基因在不同组织中的表达图
正向引物序列
正向Tm值
反向引物序列
反向Tm值
评分
AGTACAGATGCTACGGTGC
60
GGATCTGTCCTGTGATCAGG
60
AATCCCTCACAGGGAACTC
59
TGATCACAGAGTCTGGCTC
59
AGTACAGATGCTACGGTGC
60
GGATCTGTCCTGTGATCAGG
60
AGTACAGATGCTACGGTGC
60
GGATCTGTCCTGTGATCAGG
60
AGTACAGATGCTACGGTGC
60
GGATCTGTCCTGTGATCAGG
60
AGTACAGATGCTACGGTGC
60
GGATCTGTCCTGTGATCAGG
60
AGTACAGATGCTACGGTGC
60
GGATCTGTCCTGTGATCAGG
60
TGGTTATGACTTGAACTCTCC
58
TTCTTAGAAACACCTGGGAC
57
CTCCTCTTCCTCATCCTCC
58
TTTCTCTGGGTCGATGTCC
59
AGTACAGGTGCTATGGTGC
60
AGATCTGTCCTGCCATCAG
59
转录因子
影响基因
影响类型
参考文献链接(PubMed)
TRERF1
LILRB2
Repression

LILRB2基因(以及对应的蛋白质)的细胞分布位置:

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • 质膜
  • 细胞质
  • 细胞外
  • 高尔基体
  • 囊泡
  • 细胞骨架
  • 内质网
  • 细胞核
  • 内体
  • 溶酶体
  • 线粒体

LILRB2基因的本体(GO)信息:

GO库代码
对应的蛋白质
来源代码
GO:0016021
A0A0G2JLS7 (UniProtKB)
IEA
GO:0016021
A0A0G2JM05 (UniProtKB)
IEA
GO:0016021
A0A0G2JN35 (UniProtKB)
IEA
GO:0016021
A0A0G2JNE7 (UniProtKB)
IEA
GO:0016021
A0A0G2JNH0 (UniProtKB)
IEA
GO:0016021
A0A0G2JNQ7 (UniProtKB)
IEA
GO:0016021
A0A0G2JNT8 (UniProtKB)
IEA
GO:0016021
A0A0G2JPH5 (UniProtKB)
IEA
GO:0016021
H7C0C3 (UniProtKB)
IEA
GO:0002250
Q8N423 (UniProtKB)
IEA
GO:0002578
Q8N423 (UniProtKB)
IDA
GO:0002645
Q8N423 (UniProtKB)
IMP
GO:0002666
Q8N423 (UniProtKB)
IMP
GO:0002666
Q8N423 (UniProtKB)
IMP
GO:0002767
Q8N423 (UniProtKB)
IMP
GO:0002767
Q8N423 (UniProtKB)
IDA
GO:0002774
Q8N423 (UniProtKB)
IDA
GO:0004872
Q8N423 (UniProtKB)
TAS
GO:0005515
Q8N423 (UniProtKB)
IPI
GO:0005515
Q8N423 (UniProtKB)
IPI
GO:0005615
Q8N423 (UniProtKB)
IDA
GO:0005737
Q8N423 (UniProtKB)
IDA
GO:0005886
Q8N423 (UniProtKB)
TAS
GO:0005887
Q8N423 (UniProtKB)
IC
GO:0006955
Q8N423 (UniProtKB)
TAS
GO:0006968
Q8N423 (UniProtKB)
TAS
GO:0007165
Q8N423 (UniProtKB)
IMP
GO:0007165
Q8N423 (UniProtKB)
IDA
GO:0007166
Q8N423 (UniProtKB)
TAS
GO:0007267
Q8N423 (UniProtKB)
TAS
GO:0008157
Q8N423 (UniProtKB)
IPI
GO:0009986
Q8N423 (UniProtKB)
IDA
GO:0009986
Q8N423 (UniProtKB)
IDA
GO:0016020
Q8N423 (UniProtKB)
TAS
GO:0023029
Q8N423 (UniProtKB)
IPI
GO:0032396
Q8N423 (UniProtKB)
IMP
GO:0032396
Q8N423 (UniProtKB)
IMP
GO:0032396
Q8N423 (UniProtKB)
IDA
GO:0032755
Q8N423 (UniProtKB)
NAS
GO:0034113
Q8N423 (UniProtKB)
IDA
GO:0042102
Q8N423 (UniProtKB)
IDA
GO:0042130
Q8N423 (UniProtKB)
IMP
GO:0042130
Q8N423 (UniProtKB)
IDA
GO:0042130
Q8N423 (UniProtKB)
IDA
GO:0042288
Q8N423 (UniProtKB)
IDA
GO:0042288
Q8N423 (UniProtKB)
IDA
GO:0042288
Q8N423 (UniProtKB)
IPI
GO:0042288
Q8N423 (UniProtKB)
IPI
GO:0042288
Q8N423 (UniProtKB)
IPI
GO:0042288
Q8N423 (UniProtKB)
IDA
GO:0045591
Q8N423 (UniProtKB)
IMP
GO:0050776
Q8N423 (UniProtKB)
TAS
GO:0050777
Q8N423 (UniProtKB)
IC
GO:0050839
Q8N423 (UniProtKB)
IPI
GO:0051926
Q8N423 (UniProtKB)
IDA
GO:0071222
Q8N423 (UniProtKB)
IMP
GO:2001198
Q8N423 (UniProtKB)
IC

可能调控 LILRB2基因的相关microRNA:     

Reactome

String

基因与其他基因之间的相互作用关系图
序号 作用方式 资源库来源/分值 基因名称 基因名称
疾病名称 关系值 NofPmids NofSnps 来源
疾病名称 关系值 NofPmids NofSnps 来源
IGA Glomerulonephritis 0.12 1 0 CTD_human
Non-Small Cell Lung Carcinoma 0.000814326 3 0 BeFree
HIV Infections 0.000814326 3 0 BeFree
Secondary malignant neoplasm of lymph node 0.000542884 2 0 BeFree
Rheumatoid Arthritis 0.000271442 1 0 BeFree
Lupus Erythematosus, Systemic 0.000271442 1 0 BeFree
Multiple Sclerosis 0.000271442 1 0 BeFree
Leukemia, Myelocytic, Acute 0.000271442 1 0 BeFree
Adenoma 0.000271442 1 0 BeFree
Pancreatic carcinoma 0.000271442 1 0 BeFree

联系方式

山东省济南市 高新区 崇华路359号 三庆世纪财富中心C1115室

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。